Discovery and SAR of novel, potent and selective protein tyrosine phosphatase 1B inhibitors.

Bioorg Med Chem Lett

Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6098, USA.

Published: October 2003

A salicylate second site binder was linked to three classes of phosphotyrosine mimetics to produce potent protein tyrosine phosphatase 1B (PTP1B) inhibitors which exhibit significant selectivity against other phosphatases including the most homologous member, TCPTP.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(03)00725-xDOI Listing

Publication Analysis

Top Keywords

protein tyrosine
8
tyrosine phosphatase
8
discovery sar
4
sar novel
4
novel potent
4
potent selective
4
selective protein
4
phosphatase inhibitors
4
inhibitors salicylate
4
salicylate second
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!